Faculty profile

Michael Cabanero

Back to faculty

Assistant ProfessorDepartment of Laboratory Medicine & PathobiologyUniversity of Toronto

Michael Cabanero

Assistant Professor

Department of Laboratory Medicine & Pathobiology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
8 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

576

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.
JTO clinical and research reports · 2026
A Panel of Methylation-Based PCRs for Separating Mucinous Lung Adenocarcinomas From Gastrointestinal Metastases Involving the Lung.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026 · first author
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clinical Cancer Research · 2025

All 25 publications

25 publications.

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

Fan ZJ, Tudor R, Cabanero M, Le LW, Rabey M, Law JH, Stockley T, Kuang S, Meti N, Fung A, Perdrizet K, Chen K, Li JJN, Ghumman N, Ranich L, Wei C, Sabatini P, Pal P, Hsu YR, Ko HM, Schwock J, Tsao MS, Liu G, Shepherd FA, Bradbury P, Sacher A, Eng L, Leighl NB

JTO clinical and research reports2026Open Access

DOI: 10.1016/j.jtocrr.2026.101012 PMID: 42529245

A Panel of Methylation-Based PCRs for Separating Mucinous Lung Adenocarcinomas From Gastrointestinal Metastases Involving the Lung.

Cabanero M, Cao C, Sabatini P, Boruvka N, Kim HS, Zhang T, Feilotter H, Stockley T, Tsao M, Xia D

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2026First author

DOI: 10.1016/j.modpat.2026.101066 PMID: 42586242

Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.

Winquist E, Hotte SJ, Chi K, Sridhar S, Ellard S, Ong M, Iqbal N, Salim M, Emmenegger U, Gingerich JR

Clinical Cancer Research202511 citations

DOI: 10.1158/1078-0432.ccr-24-1612

Tissue Prior to the Initial Hematoxylin-Eosin Section Demonstrates Value as an Alternative Source of DNA for Molecular Testing.

Sabatini P, Ta R, Peralta M, Anderson M, Khan S, Belcastro R, Arruda A, Minden MD, Cabanero M, Prica A, Zhang T, Kridel R, Stockley T, Xia D

Archives of pathology & laboratory medicine20251 citationsOpen Access

DOI: 10.5858/arpa.2024-0222-oa PMID: 39786946

Reproducibility of Assessment of Lepidic (Noninvasive) Patterns in Lung Adenocarcinoma With Cytokeratin Immunostain Compared With Hematoxylin and Eosin and the Proposed New International Association for the Study of Lung Cancer (IASLC) Algorithm.

Yang E, Alshamlan N, Hueniken K, Weiss J, Cabanero M, Tsao MS

JTO clinical and research reports2024Open Access

DOI: 10.1016/j.jtocrr.2024.100682 PMID: 39100653

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.

Mirhadi S, Tam S, Li Q, Moghal N, Pham NA, Tong J, Golbourn BJ, Krieger JR, Taylor P, Li M, Weiss J, Martins-Filho SN, Raghavan V, Mamatjan Y, Khan AA, Cabanero M, Sakashita S, Huo K, Agnihotri S, Ishizawa K, Waddell TK, Zadeh G, Yasufuku K, Liu G, Shepherd FA, Moran MF, Tsao MS

Nature communications202258 citationsOpen Access

DOI: 10.1038/s41467-022-29444-9 PMID: 35383171

Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.

Kuang S, Fung AS, Perdrizet KA, Chen K, Li JJN, Le LW, Cabanero M, Karsaneh OAA, Tsao MS, Morganstein J, Ranich L, Smith AC, Wei C, Cheung C, Shepherd FA, Liu G, Bradbury P, Pal P, Schwock J, Sacher AG, Law JH, Stockley TL, Leighl NB

Current oncology (Toronto, Ont.)202223 citationsOpen Access

DOI: 10.3390/curroncol29070352 PMID: 35877212

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.

Ul Haq S, Schmid S, Aparnathi MK, Hueniken K, Zhan LJ, Sacdalan D, Li JJN, Meti N, Patel D, Cheng D, Philip V, Tsao MS, Cabanero M, de Carvalho D, Liu G, Bratman SV, Lok BH

iScience202222 citationsOpen Access

DOI: 10.1016/j.isci.2022.105487 PMID: 36425756

Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.

Cho BCJ, Donahoe L, Bradbury PA, Leighl N, Keshavjee S, Hope A, Pal P, Cabanero M, Czarnecka K, McRae K, Tsao MS, de Perrot M

The Lancet. Oncology202164 citations

DOI: 10.1016/s1470-2045(20)30606-9 PMID: 33450184

Prevalence and Heterogeneity of PD-L1 Expression by 22C3 Assay in Routine Population-Based and Reflexive Clinical Testing in Lung Cancer.

Hwang DM, Albaqer T, Santiago RC, Weiss J, Tanguay J, Cabanero M, Leung Y, Pal P, Khan Z, Lau SCM, Sacher A, Torlakovic E, Cheung C, Tsao MS

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer202156 citationsOpen Access

DOI: 10.1016/j.jtho.2021.03.028 PMID: 33915250

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Michael Cabanero

Research

Latest papers

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

A Panel of Methylation-Based PCRs for Separating Mucinous Lung Adenocarcinomas From Gastrointestinal Metastases Involving the Lung.

Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.

Tissue Prior to the Initial Hematoxylin-Eosin Section Demonstrates Value as an Alternative Source of DNA for Molecular Testing.

Reproducibility of Assessment of Lepidic (Noninvasive) Patterns in Lung Adenocarcinoma With Cytokeratin Immunostain Compared With Hematoxylin and Eosin and the Proposed New International Association for the Study of Lung Cancer (IASLC) Algorithm.

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.

Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.

Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.

Prevalence and Heterogeneity of PD-L1 Expression by 22C3 Assay in Routine Population-Based and Reflexive Clinical Testing in Lung Cancer.

Frequent collaborators

Ming Tsao

Ming-Sound Tsao

Geoffrey Liu

Prodipto Pal

Adrian Sacher

Kazuhiro Yasufuku

Tracy Stockley

Peter Sabatini

Penelope Bradbury

Lesley Seymour

Shaf Keshavjee

Scott Bratman

Nadeem Moghal

Cuihong Wei

Joerg Schwock

Emina Torlakovic

Marc de Perrot

Laura Donahoe

David Hwang

Thomas Waddell

Michael Moran

Benjamin Lok

Dongsheng Tu

Gelareh Zadeh

Trevor Pugh

Rachel Goodwin

Philippe Bedard

Natasha Leighl

Karen Mcrae

Mini Pakkal

Roula Albadine

Muhammad Salim

Runjan Chetty

Nayyer Iqbal

Ilan Weinreb

Ellen Yang

Robert Ta

Alina Lalani

Andrew Hope

Kate Hanneman